Professor Matt Trau
Professor

Matt Trau

Email: 

Background

Professor Matt Trau is currently a Professor of Chemistry at The University of Queensland (UQ); and is also Senior Group Leader and co-founder of the Australian Institute for Bioengineering and Nanotechnology. Since graduating from the University of Sydney (BSc Hons I, University Medal) and the University of Melbourne (PhD in Physical Chemistry, 1993), he has held positions in industry and academia across the globe. These include a Fulbright Research Fellowship at Princeton University, USA; and a research scientist at Dow Chemical and ICI Pty Ltd. Professor Trau has been a Visiting Professor at two of the largest Cancer Research Centres in the world: The Dana Farber Cancer Research Institute, Harvard Medical School, Boston (2000); and the Fred Hutchinson Cancer Research Centre, Seattle (2008). Professor Trau is internationally recognised for his innovative and cross-disciplinary research at the interface between chemistry, nanotechnology, biology and medicine. He has co-authored more than 290 refereed publications, many of which appear in the highest impact journals in his field, e.g., fifteen Science and Nature family publications. His major awards and honours include an ARC Laureate Fellowship, an ARC Federation Fellowship (amoungst the most prestigious scientific fellowships in Australia), a Fulbright Research Fellowship to the USA; a Queensland Young Tall Poppy Award; a UQ Foundation/Vice Chancellor’s Research Excellence Award; a Paul Harris Fellowship; and a Pink Circle Award for breast cancer research excellence.

Availability

Professor Matt Trau is:
Available for supervision
Media expert

Fields of research

Macromolecular and materials chemistry Physical chemistry

Qualifications

  • Bachelor (Honours) of Science (Advanced), University of Sydney
  • Doctor of Philosophy, University of Melbourne

Research impacts

Research

Nanoscience, Nanotechnology, Molecular diagnostics.

Leadership of major multi-disciplinary international programs

Professor Trau has raised more than $22 million in competitive national and international grant funding in the past 10 years. In the last five years, Professor Trau has initiated and led several large international programs that involve close collaboration between leading nanotechnologists, molecular biologists, geneticists and commercial researchers - with the goal of creating cutting edge diagnostics. These include a $4 million National and International Research Alliances Program (NIRAP) grant from the Queensland government ("International Partnership for preventative and Personalised Medicine)"; and two consecutive $5 million multidisciplinary collaborative grants from the National Breast Cancer Foundation (NBCF): "Novel strategies for Prediction and Control of Advanced Breast Cancer via Nanoscaled Epigenetic-Based Biosensors", 2008-2013; and "Enabling Clinical Epigenetic Diagnostics: The Next Generation of Personalized Breast Cancer Care", 2013-2018. These grants involve research collaborations with some of the highest calibre scientists in the world, e.g., Dr Lee Hartwell (2001 Nobel Laureate) from Seattle was a co-chief investigator on the NIRAP grant, and each of the NBCF grants include leading geneticists, pathologists and oncologists from across Australia and around the world. In the past five years, he has been a consultant for a range of national and international companies such as Merck, Digene, Beckman Coulter, Panbio and A.I. Scientific, as well as being the founder and Director of Nanomics BioSystems Pty Ltd (a spinoff company from his laboratory).

Major plenary lectures and international conferences

Since 2003, Professor Trau has presented more than 60 invited plenary/keynote lectures at major international conferences spanning the disciplines of Chemistry, Nanotechnology, Chemical Engineering, Cancer and Diagnostics. Recent examples include: the 4th International NanoBio Conference, (Seattle) 2012; the 14th International Colloid & Surface Science Conference, (Japan) 2012; "Cancer Nanotechnology" Gordon Research Conference, (USA) 2011; the WA Cancer Conference 2011; Sydney Cancer Conference, 2010. In the past 10 years, Professor Trau has played the role of conference convenor, chair, co-chair and symposium chair for 10 major international conferences. Recent examples include: immediate past chair of the 1st International Conference on BioNano Innovation, (Brisbane) 2012; co-chair of the 5th International NanoBio Conference scheduled for Brisbane in 2014.

Search Professor Matt Trau’s works on UQ eSpace

319 works between 1988 and 2025
All (319) Journal Article (276) Book Chapter (11) Conference Publication (30) Book (1) Edited Outputs (1)

81 - 100 of 319 works

2019

Journal Article

Merging new-age biomarkers and nanodiagnostics for precision prostate cancer management

Koo, Kevin M., Mainwaring, Paul N., Tomlins, Scott A. and Trau, Matt (2019). Merging new-age biomarkers and nanodiagnostics for precision prostate cancer management. Nature Reviews Urology, 16 (5), 302-317. doi: 10.1038/s41585-019-0178-2

Merging new-age biomarkers and nanodiagnostics for precision prostate cancer management

2019

Journal Article

A microfluidic-SERSplatform for isolation and immuno-phenotyping of antigen specific T-cells

Dey, Shuvashis, Vaidyanathan, Ramanathan, Reza, K. Kamil, Wang, Jing, Wang, Yuling, Nel, Hendrik J., Law, Soi-Cheng, Tyler, Jennifer, Rossjohn, Jamie, Reid, Hugh H., Ibn Sina, Abu Ali, Thomas, Ranjeny and Trau, Matt (2019). A microfluidic-SERSplatform for isolation and immuno-phenotyping of antigen specific T-cells. Sensors and Actuators B: Chemical, 284, 281-288. doi: 10.1016/j.snb.2018.12.099

A microfluidic-SERSplatform for isolation and immuno-phenotyping of antigen specific T-cells

2019

Journal Article

Optimizing size exclusion chromatography for extracellular vesicle enrichment and proteomic analysis from clinically relevant samples

Lane, Rebecca E., Korbie, Darren, Trau, Matt and Hill, Michelle M. (2019). Optimizing size exclusion chromatography for extracellular vesicle enrichment and proteomic analysis from clinically relevant samples. Proteomics, 19 (8) 1800156, 1800156. doi: 10.1002/pmic.201800156

Optimizing size exclusion chromatography for extracellular vesicle enrichment and proteomic analysis from clinically relevant samples

2019

Journal Article

Reading conformational changes in proteins with a new colloidal-based interfacial biosensing system

Ahmed, Mostak, Carrascosa, Laura G., Mainwaring, Paul and Trau, Matt (2019). Reading conformational changes in proteins with a new colloidal-based interfacial biosensing system. ACS Applied Materials and Interfaces, 11 (12) acsami.8b18269, 11125-11135. doi: 10.1021/acsami.8b18269

Reading conformational changes in proteins with a new colloidal-based interfacial biosensing system

2019

Journal Article

A high-resolution study of in situ surface-enhanced Raman scattering nanotag behavior in biological systems

Wang, Jing, Anderson, Will, Li, Junrong, Lin, Lynlee L., Wang, Yuling and Trau, Matt (2019). A high-resolution study of in situ surface-enhanced Raman scattering nanotag behavior in biological systems. Journal of Colloid and Interface Science, 537, 536-546. doi: 10.1016/j.jcis.2018.11.035

A high-resolution study of in situ surface-enhanced Raman scattering nanotag behavior in biological systems

2019

Conference Publication

Interaction of PIK3CA mutation subclasses with response to preoperative treatment with the PI3K inhibitor pictilisib in patients with estrogen receptor-positive breast cancer

Schmid, P., Pinder, S., Wheatley, D., Zummit, C., Macaskill, E. J., Hu, J., Price, R., Bundred, N., Hadad, S., Shia, A., Sarker, S-J, Lim, L., Mousa, K., O'Brien, C., Wilson, T. R., Lackner, M. R., Gendreau, S., Gazinska, P., Korbie, D., Trau, M., Mainwaring, P., Thompson, A. and Purushotham, A. (2019). Interaction of PIK3CA mutation subclasses with response to preoperative treatment with the PI3K inhibitor pictilisib in patients with estrogen receptor-positive breast cancer. San Antonio Breast Cancer Symposium, San Antonio, TX, United States, 4-8 December 2018. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.SABCS18-P2-08-02

Interaction of PIK3CA mutation subclasses with response to preoperative treatment with the PI3K inhibitor pictilisib in patients with estrogen receptor-positive breast cancer

2019

Journal Article

PrimerROC: accurate condition-independent dimer prediction using ROC analysis

Johnston, Andrew D., Lu, Jennifer, Ru, Ke-lin, Korbie, Darren and Trau, Matt (2019). PrimerROC: accurate condition-independent dimer prediction using ROC analysis. Scientific Reports, 9 (1) 209, 209. doi: 10.1038/s41598-018-36612-9

PrimerROC: accurate condition-independent dimer prediction using ROC analysis

2019

Journal Article

Two-photon nanolithography of tailored hollow three-dimensional microdevices for biosystems

Liao, Caizhi, Anderson, Will, Antaw, Fiach and Trau, Matt (2019). Two-photon nanolithography of tailored hollow three-dimensional microdevices for biosystems. ACS Omega, 4 (1), 1401-1409. doi: 10.1021/acsomega.8b03164

Two-photon nanolithography of tailored hollow three-dimensional microdevices for biosystems

2019

Journal Article

Label-free detection of exosomes using surface plasmon resonance biosensor

Sina, A.A.I., Vaidyanathan, R., Wuethrich, A., Carrascosa, L. G. and Trau, M. (2019). Label-free detection of exosomes using surface plasmon resonance biosensor. Analytical and Bioanalytical Chemistry, 411 (7), 1311-1318. doi: 10.1007/s00216-019-01608-5

Label-free detection of exosomes using surface plasmon resonance biosensor

2019

Journal Article

Tracking antigen specific T-cells: technological advancement and limitations

Dey, Shuvashis, Kamil Reza, K., Wuethrich, Alain, Korbie, Darren, Ibn Sina, Abu Ali and Trau, Matt (2019). Tracking antigen specific T-cells: technological advancement and limitations. Biotechnology Advances, 37 (1), 145-153. doi: 10.1016/j.biotechadv.2018.11.010

Tracking antigen specific T-cells: technological advancement and limitations

2019

Journal Article

Phosphoprotein biosensors for monitoring pathological protein structural changes

Ahmed, Mostak, Koo, Kevin M., Mainwaring, Paul N., Carrascosa, Laura G. and Trau, Matt (2019). Phosphoprotein biosensors for monitoring pathological protein structural changes. Trends in Biotechnology, 38 (5), 519-531. doi: 10.1016/j.tibtech.2019.11.006

Phosphoprotein biosensors for monitoring pathological protein structural changes

2019

Conference Publication

Design and clinical validation of surface enhanced Raman spectroscopy nanodiagnostic technology for urinary prostate cancer risk prediction

Gardiner, F., Koo, K., Wang, J., Richards, R., Farrell, A., Yaxley, J., Samaratunga, H., Teloken, P., Roberts, M., Coughlin, G., Lavin, M., Mainwaring, P., Wang, Y., Gardiner, R. and Trau, M. (2019). Design and clinical validation of surface enhanced Raman spectroscopy nanodiagnostic technology for urinary prostate cancer risk prediction. Annual Scientific Meeting of the Urological Society of Australia and New-Zealand, Brisbane, QLD Australia, 13-16 April 2019. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Design and clinical validation of surface enhanced Raman spectroscopy nanodiagnostic technology for urinary prostate cancer risk prediction

2018

Journal Article

An integrated multi-molecular sensor for simultaneous BRAFV600E protein and DNA single point mutation detection in circulating tumour cells

Dey, Shuvashis, Koo, Kevin, Wang, Zhaoran, Sina, Abu Ali Ibn, Wuethrich, Alain and Trau, Matt (2018). An integrated multi-molecular sensor for simultaneous BRAFV600E protein and DNA single point mutation detection in circulating tumour cells. Lab on a Chip, 19 (5), 738-748. doi: 10.1039/c8lc00991k

An integrated multi-molecular sensor for simultaneous BRAFV600E protein and DNA single point mutation detection in circulating tumour cells

2018

Journal Article

A sample-to-targeted gene analysis biochip for nanofluidic manipulation of solid-phase circulating tumor nucleic acid amplification in liquid biopsies

Koo, Kevin M., Dey, Shuvashis and Trau, Matt (2018). A sample-to-targeted gene analysis biochip for nanofluidic manipulation of solid-phase circulating tumor nucleic acid amplification in liquid biopsies. ACS Sensors, 3 (12) acssensors.8b01011, 2597-2603. doi: 10.1021/acssensors.8b01011

A sample-to-targeted gene analysis biochip for nanofluidic manipulation of solid-phase circulating tumor nucleic acid amplification in liquid biopsies

2018

Journal Article

Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker

Sina, Abu Ali Ibn, Carrascosa, Laura G., Liang, Ziyu, Grewal, Yadveer S., Wardiana, Andri, Shiddiky, Muhammad J. A., Gardiner, Robert A., Samaratunga, Hemamali, Gandhi, Maher K., Scott, Rodney J., Korbie, Darren and Trau, Matt (2018). Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker. Nature Communications, 9 (1) 4915, 4915. doi: 10.1038/s41467-018-07214-w

Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker

2018

Journal Article

A SERS microfluidic platform for targeting multiple soluble immune checkpoints

Reza, K. Kamil, Sina, Abu Ali Ibn, Wuethrich, Alain, Grewal, Yadveer S., Howard, Christopher B., Korbie, Darren and Trau, Matt (2018). A SERS microfluidic platform for targeting multiple soluble immune checkpoints. Biosensors and Bioelectronics, 126, 178-186. doi: 10.1016/j.bios.2018.10.044

A SERS microfluidic platform for targeting multiple soluble immune checkpoints

2018

Journal Article

"Mix-to-go" silver colloidal strategy for prostate cancer molecular profiling and risk prediction

Wang, Jing, Koo, Kevin M., Wang, Yuling and Trau, Matt (2018). "Mix-to-go" silver colloidal strategy for prostate cancer molecular profiling and risk prediction. Analytical Chemistry, 90 (21), 12698-12705. doi: 10.1021/acs.analchem.8b02959

"Mix-to-go" silver colloidal strategy for prostate cancer molecular profiling and risk prediction

2018

Journal Article

Facile one-pot synthesis of nanodot-decorated gold-silver alloy nanoboxes for single-particle surface-enhanced raman scattering activity

Li, Junrong, Zhang, Guannan, Wang, Jing, Maksymov, Ivan S., Greentree, Andrew D., Hu, Jiming, Shen, Aiguo, Wang, Yuling and Trau, Matt (2018). Facile one-pot synthesis of nanodot-decorated gold-silver alloy nanoboxes for single-particle surface-enhanced raman scattering activity. ACS Applied Materials and Interfaces, 10 (38), 32526-32535. doi: 10.1021/acsami.8b10112

Facile one-pot synthesis of nanodot-decorated gold-silver alloy nanoboxes for single-particle surface-enhanced raman scattering activity

2018

Journal Article

Parallel profiling of cancer cells and proteins using a graphene oxide functionalized ac-EHD SERS immunoassay

Reza, K. Kamil, Dey, Shuvashis, Wuethrich, Alain, Sina, Abu Ali Ibn, Korbie, Darren, Wang, Yuling and Trau, Matt (2018). Parallel profiling of cancer cells and proteins using a graphene oxide functionalized ac-EHD SERS immunoassay. Nanoscale, 10 (39), 18482-18491. doi: 10.1039/c8nr02886a

Parallel profiling of cancer cells and proteins using a graphene oxide functionalized ac-EHD SERS immunoassay

2018

Journal Article

Multiplexed SERS detection of soluble cancer protein biomarkers with gold-silver alloy nanoboxes and nanoyeast single-chain variable fragments

Li, Junrong, Wang, Jing, Grewal, Yadveer S, Howard, Christopher B, Raftery, Lyndon J, Mahler, Stephen, Wang, Yuling and Trau, Matt (2018). Multiplexed SERS detection of soluble cancer protein biomarkers with gold-silver alloy nanoboxes and nanoyeast single-chain variable fragments. Analytical Chemistry, 90 (17) acs.analchem.8b02216, 10377-10384. doi: 10.1021/acs.analchem.8b02216

Multiplexed SERS detection of soluble cancer protein biomarkers with gold-silver alloy nanoboxes and nanoyeast single-chain variable fragments

Current funding

  • 2024 - 2026
    ALL IN - AI and Laboratory Led IdentificatioN of PASC
    NHMRC MRFF Post-Acute Sequelae of COVID-19
    Open grant
  • 2024 - 2028
    Digital chemistry and catalysis: redefining reactions in confined systems
    ARC Australian Laureate Fellowships
    Open grant
  • 2023 - 2027
    Rhythms and blues: Personalising care for body clock dysfunction in mood disorders (NHMRC Synergy grant administered by University of Sydney)
    University of Sydney
    Open grant
  • 2021 - 2028
    Immunostorm Chip Research
    Evolution Mining Limited
    Open grant
  • 2021 - 2025
    The amplification of DNA from environmental metazoan cells (enCells)
    CSIRO
    Open grant

Past funding

  • 2022 - 2025
    nanoIMPAC: Monitoring immune toxicities and tumour immune evasion in lung cancer
    Cancer Australia
    Open grant
  • 2022 - 2025
    An integrated nano-bioengineered chip for enhanced molecular evolution
    ARC Discovery Projects
    Open grant
  • 2022 - 2023
    Whole exome and transcriptome profiling of patients with advanced cutaneous squamous cell carcinoma exposed to immunotherapy: C-Seq STUDY (Research Support Scheme Project Grant led by Metro South HHS)
    Metro South Hospital and Health Service
    Open grant
  • 2021 - 2022
    Cannabis genetic marker development for the breeding of medicinal cannabis varieties
    CannaPacific Pty Ltd
    Open grant
  • 2021 - 2023
    Single molecule sensing on nanopillars: Reading complex molecular circuits
    ARC Discovery Projects
    Open grant
  • 2020 - 2022
    Early detection of lung cancer (NHMRC Ideas Grant led by The Council of the Queensland Institute of Medical Research)
    Queensland Institute of Medical Research
    Open grant
  • 2019 - 2022
    The Development and Clinical Translation of Blood-Based Diagnostics for Brain Cancer (Mark Hughes Foundation administered by the University of Newcastle)
    University of Newcastle
    Open grant
  • 2018 - 2021
    Genomics markers in breast cancer
    Queen Mary University of London
    Open grant
  • 2018
    Combined TMPRSS2:ERG, PCA3 and SChLAP1 RNA in Urine for selective detection of Aggressive Prostate Cancer
    Metro North Hospital and Health Service
    Open grant
  • 2018 - 2021
    DNA exhibits new self-assembled structures due to clustered DNA methylation
    ARC Discovery Projects
    Open grant
  • 2018 - 2022
    Integrating immunity and genetics in Follicular Lymphoma to establish a prognostic score fit for the modern era
    NHMRC Project Grant
    Open grant
  • 2018
    Queensland Bladder Cancer Initiative (PA Research Foundation Grant administered by the Queensland University of Technology)
    Queensland University of Technology
    Open grant
  • 2016 - 2017
    QMUL Research Project 1
    Queen Mary University of London
    Open grant
  • 2016 - 2019
    Rapid detection and quantitation of Campylobacter jejuni/coli in processing.
    Queensland Department of Agriculture and Fisheries
    Open grant
  • 2016 - 2018
    AC electrohydrodynamics in microfluidic devices
    UniQuest Pty Ltd
    Open grant
  • 2016
    Does prostatic manipulation result in increased numbers and clusters of circulating tumour cells?
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2016
    Exosome and Bio/Nanoparticle Characterisation Facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016 - 2018
    Trapping and Watching Biomolecular Complexes near Nanopores
    ARC Discovery Projects
    Open grant
  • 2014 - 2015
    Optimisation of the single drop genomics assay to detect food pathogens
    Australian Centre for International Agricultural Research
    Open grant
  • 2014 - 2016
    Tuneable 'Nano-Shearing': An Innovative Mechanism for the Accurate and Specific Capture of Cells and Molecules
    ARC Discovery Projects
    Open grant
  • 2013 - 2019
    Enabling Clinical Epigenetic Diagnostics: The Next Generation of Personalized Breast Cancer Care
    National Breast Cancer Foundation
    Open grant
  • 2012
    An intergrated fluidic circuit system for digital PCR analysis, single-cell gene- expression, and high-throughput preparation of next-generation sequencing libraries.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2011
    Mass spectrometer for biomolecule discovery, structural analysis and quantification.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010
    Fabrication and Testing Facilites for Mono-Dispersed Nanoporous Spheres in Advanced Bio-applications
    UQ Major Equipment and Infrastructure
    Open grant
  • 2009 - 2012
    Accelerated Molecular Probe Pipeline
    Seattle Biomedical Research Institute
    Open grant
  • 2008 - 2013
    Novel strategies for prediction and control of advanced breast cancer via nanoscaled epigenetic-based biosensors
    National Breast Cancer Foundation
    Open grant
  • 2008 - 2011
    Nanoscaled biosensors: reading epigenetic signatures to improve breast cancer detection and treatment
    Cancer Australia
    Open grant
  • 2008
    A high-throughput facility for the identification and analysis of gene regulatory elements and factors
    UQ Major Equipment and Infrastructure
    Open grant
  • 2008
    Advanced environmental and process analysis facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2008
    Automated Microvave Reactor for Polymer Chemistry, Materials Development and Nanotechnology
    UQ Major Equipment and Infrastructure
    Open grant
  • 2008
    Quantitative Particle and Cell Size Distribution Facility: Accelerating the Development of Advanced Materials, Water Treamtnet and Mineral Processing at UQ
    UQ Major Equipment and Infrastructure
    Open grant
  • 2008
    Solid State NMR Console
    UQ Major Equipment and Infrastructure
    Open grant
  • 2007 - 2010
    Novel Nanotechnology Platforms for Disease Biomarker Diagnostics
    Queensland Government Smart State National and International Research Alliances Program
    Open grant
  • 2007
    Early detection of breast cancer via nanoscaled biomarker discovery and diagnostics
    National Breast Cancer Foundation
    Open grant
  • 2006
    Real time PCR and nanoparticle diagnostic facilities for high-throughput quantitative analysis of genomic structure and gene expression
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2005 - 2007
    Multiplexed Molecular Reading of Protein Associations via Nanoscaled Devices
    ARC Discovery Projects
    Open grant
  • 2004 - 2009
    Beyond Microarrays: Nano-Scaled Devices for High Throughput Biomolecular Sensing
    ARC Federation Fellowships
    Open grant
  • 2004 - 2006
    DEST INNOVATION ACCESS PROGRAMME: INTERNATIONAL SCIENCE LINKAGES - OzNano2Life: Australian Nanobiotechnology Cluster Integrated with a European Union Network of Excellence
    University of Technology Sydney
    Open grant
  • 2003 - 2010
    ARC Centre of Excellence for Functional Nanomaterials (administered by UNSW from September 2012 onwards)
    ARC Centres of Excellence
    Open grant
  • 2003
    DEVELOPMENT OF A NOVEL BIOMATERIAL FOR BONE TISSUE ENGINEERING
    ARC Discovery Projects
    Open grant
  • 1999
    Biomaterials and Nanotechnology Research Initiative
    UQ Foundation Research Excellence Awards - DVC(R) Funding
    Open grant
  • 1999
    Designed nanostructured materials through bi-inspired assembly
    UQ External Support Enabling Grant
    Open grant
  • 1999 - 2001
    Designed nanostructures for Ti02-based solar cells
    Sustainable Technologies Australia
    Open grant
  • 1999 - 2001
    Designed nanostructures for Ti02-based solar cells
    Sustainable Technologies Australia
    Open grant
  • 1999 - 2001
    Self-assembled membranes for protection of foreign tissue transplants
    ARC Australian Research Council (Large grants)
    Open grant
  • 1998
    Mechanistic Studies of the Anti-HIV drug FP-21399
    UQ Foundation
    Open grant
  • 1998 - 2000
    Rapid DNA sequencing by hybridization of a patterned colloidal array
    ARC Australian Research Council (Large grants)
    Open grant
  • 1997
    Febrication of nanostructured ceramic materials and devices
    ARC Australian Research Council (Small grants)
    Open grant
  • 1997
    Rapid DNA sequencing by hybridization of a patterned colloidal array
    University of Queensland New Staff Research Grant
    Open grant

Availability

Professor Matt Trau is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Utilising extracellular vesicles for the diagnosis of lung cancer.

    Principal Advisor

    Other advisors: Dr Alain Wuethrich, Dr Richard Lobb

  • Doctor Philosophy

    A nano-engineered chip to help manage acute and long-haul COVID-19 patients

    Principal Advisor

    Other advisors: Dr Alain Wuethrich

  • Doctor Philosophy

    Towards n-plex quantification of molecular interactions for evolution-free biopanning

    Principal Advisor

    Other advisors: Dr Christopher Howard

  • Doctor Philosophy

    Single Molecule Readout of Immune Disfunction

    Principal Advisor

    Other advisors: Dr Richard Lobb, Dr Alain Wuethrich

  • Doctor Philosophy

    Towards n-plex quantification of molecular interactions for evolution-free biopanning

    Principal Advisor

    Other advisors: Dr Christopher Howard

  • Doctor Philosophy

    Towards n-plex quantification of molecular interactions for evolution-free biopanning

    Principal Advisor

    Other advisors: Dr Christopher Howard

  • Doctor Philosophy

    Single-nanoparticle upconversion nanolasers for probing biological systems

    Principal Advisor

  • Doctor Philosophy

    Digital Nanotechnologies to track molecular aberrations in cancer

    Principal Advisor

    Other advisors: Dr Richard Lobb, Dr Alain Wuethrich

  • Doctor Philosophy

    Chemical Reactions in Confined Systems

    Principal Advisor

    Other advisors: Professor Debra Bernhardt

  • Doctor Philosophy

    Single-nanoparticle upconversion nanolasers for probing biological systems

    Principal Advisor

  • Doctor Philosophy

    Multi-Factor Authentication of Extracellular Vesicles in Clinical Settings

    Principal Advisor

    Other advisors: Dr Richard Lobb, Dr Alain Wuethrich

  • Doctor Philosophy

    Utilising extracellular vesicles for the diagnosis of lung cancer.

    Principal Advisor

    Other advisors: Dr Richard Lobb, Dr Alain Wuethrich

  • Doctor Philosophy

    Harnessing nanotechnology to unravel the phenotypic heterogeneity of extracellular vesicles

    Associate Advisor

    Other advisors: Dr Abu Sina, Associate Professor Mitchell Stark, Dr Alain Wuethrich

  • Doctor Philosophy

    A potential pan-cancer diagnostic utilizing DNA methylation landscapes

    Associate Advisor

    Other advisors: Dr Abu Sina

  • Master Philosophy

    Digital catalysis and digital chemistry

    Associate Advisor

    Other advisors: Dr Shuvashis Dey

  • Doctor Philosophy

    A nano-map of cytokines in skin: Personalising treatment of skin inflammation by a digital nanotechnology

    Associate Advisor

    Other advisors: Associate Professor Mitchell Stark, Dr Alain Wuethrich

  • Doctor Philosophy

    Single molecule sensing on nanopillars: Reading complex molecular circuits

    Associate Advisor

    Other advisors: Dr Alain Wuethrich, Dr Abu Sina

  • Doctor Philosophy

    Digital nanotechnologies for profiling trace immune dysregulations and tissue damage in emerging diseases

    Associate Advisor

    Other advisors: Dr Alain Wuethrich

  • Doctor Philosophy

    Investigating therapeutic potentials of brain-derived exosomes

    Associate Advisor

    Other advisors: Dr Christopher Howard, Dr Richard Lobb

  • Doctor Philosophy

    A nano-map of cytokines in skin: Personalising treatment of skin inflammation by a digital nanotechnology

    Associate Advisor

    Other advisors: Associate Professor Mitchell Stark, Dr Alain Wuethrich

  • Doctor Philosophy

    An integrated nano-bioengineered chip for enhanced molecular evolution

    Associate Advisor

    Other advisors: Dr Christopher Howard

  • Doctor Philosophy

    Digital nanotechnologies to unravel immune dysregulation in long COVID

    Associate Advisor

    Other advisors: Dr Alain Wuethrich

  • Doctor Philosophy

    Development of next-generation molecular tools for diagnostics

    Associate Advisor

    Other advisors: Dr Christopher Howard

  • Doctor Philosophy

    Surface engineering of nanoyeast

    Associate Advisor

    Other advisors: Dr Christopher Howard

  • Doctor Philosophy

    The investigation of microglial activation in brain cancer and brain metastasis by an integrated nano-sensor

    Associate Advisor

    Other advisors: Dr Alain Wuethrich, Dr Richard Lobb

  • Doctor Philosophy

    Advanced Micro and Nano Engineered Sensors for Post Translational Modification based Liquid Biopsy Analysis of Cancer

    Associate Advisor

    Other advisors: Dr Abu Sina, Dr Alain Wuethrich

  • Doctor Philosophy

    Development of next-generation molecular tools for diagnostics

    Associate Advisor

    Other advisors: Dr Christopher Howard

  • Doctor Philosophy

    A potential pan-cancer diagnostic utilizing DNA methylation landscapes

    Associate Advisor

    Other advisors: Dr Abu Sina

Completed supervision

Enquiries

Contact Professor Matt Trau directly for media enquiries about:

  • Biomarkers
  • Biosensors
  • Breast cancer
  • Cancer
  • Colloid science
  • Diagnostics cancer
  • Materials science
  • Medicine - personalised
  • Nanobiotechnology
  • Nanotechnology
  • Personalised medicine
  • Physical Chemistry
  • Preventative medicine
  • Surface science

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au